<DOC>
	<DOCNO>NCT01049217</DOCNO>
	<brief_summary>The purpose study evaluate efficacy pregabalin compare placebo reduce neuropathic pain associate HIV neuropathy .</brief_summary>
	<brief_title>Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy</brief_title>
	<detailed_description>Based DMC interim efficacy analysis result indicate low probability success study terminate April 2 , 2012 ; termination unrelated safety finding could impact patient health .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Men woman , age 18 great Documented evidence HIV1 infection Documented diagnosis HIVassociated Distal Symmetrical Polyneuropathy ( DSP ) subjective sensory symptom pain Pain start foot Subject untreated vitamin B12 deficiency ( serum B12 level &lt; 200 pg/ml ) treat B12 deficiency treatment le 6 month B12 supplementation ( injection intranasal B12 ) prior screen Diabetes mellitus require regular medical treatment ( diet exercise ) HbA1C &gt; 6.9 Subjects peripheral neuropathic pain associate HIV infection ; include subject condition : Post Herpetic Neuralgia ( PHN ) , Diabetic Peripheral Neuropathy ( DPN ) , familial neuropathy ; compression relate neuropathy , radicular pain , infection relate neuropathy ( eg , leprosy ) ; neuropathy relate : metabolic abnormality ; nutritional factor ; vascular insult ; inflammation ; autoimmune disease ; malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>neuropathy</keyword>
	<keyword>pain</keyword>
	<keyword>HIV-1</keyword>
	<keyword>HIV Infections</keyword>
</DOC>